Neuro-Oncology News

by Leah Christl, PhD

Patients diagnosed with glioblastoma appeared more likely to undergo treatment and survive longer if they sought care at high-volume facilities, according to study results.

Five ASCO members have been elected to the society’s board of directors to fill existing vacancies.

Howard A. “Skip” Burris III, MD, FACP, FASCO, has been elected to serve as president of ASCO for the 2019-2020 term.

States with expanded Medicaid under the Affordable Care Act demonstrated an increase in cancer diagnoses, especially early-stage cancer diagnoses, according to study results.

Viviane Tabar, MD, has been appointed chair of the department of neurosurgery at Memorial Sloan Kettering Cancer Center.

SAN ANTONIO — Creating a dynamic regulatory environment requires the FDA is responsive to societal demands in conjunction with emerging scientific advances, according to Richard Pazdur, MD.

Results of a study published in Neuro-Oncology indicate a high failure rate of phase 3 trials for glioblastoma, the most common primary malignant brain tumor among adults.

The CDC has released a public-use research database that combines data from CDC’s National Program of Cancer Registries and NCI’s SEER program.

Children diagnosed with cancer and insured by Medicaid had similar survival rates as privately insured children, according to the results of a study published in Cancer.